Current Neuropharmacology
Title:Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
Volume: 19 Issue: 2
Author(s): Seyed Mohammad Nabavi*Eduardo Sobarzo-Sánchez*
Affiliation:
- Applied Biotechnology Research Center Baqiyatallah University of Medical Sciences Tehran, Sheikh Bahaei St., 19945-546,Iran
- Grupo de Investigación en Química Médica y Bio-inorgánica (QMEDBIN) Facultad de Ciencias de la Salud Universidad Central de Chile Lord Cochrane 417, Santiago,Spain
Export Options
About this article
Cite this article as:
Nabavi Mohammad Seyed *, Sobarzo-Sánchez Eduardo *, Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times, Current Neuropharmacology 2021; 19 (2) . https://dx.doi.org/10.2174/1570159X1902201231153120
DOI https://dx.doi.org/10.2174/1570159X1902201231153120 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice
Current Alzheimer Research Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Subcellular Analysis of the Platelet Proteome
Current Proteomics The Role of Berberine in the Multi-Target Treatment of Senile Dementia
Current Topics in Medicinal Chemistry Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents Novel Technologies for Dipeptide Drugs Design and their Implantation
Current Pharmaceutical Design Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents
Mini-Reviews in Medicinal Chemistry Pharmacological Management of Acutely Agitated Schizophrenic Patients
Current Pharmaceutical Design Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Drug Development of Small-Molecule Inhibitors of AD-Relevant Kinases as Novel Perspective Multitargeted Approach
Current Alzheimer Research Non-viral Gene Delivery and Therapeutics Targeting to Brain
Current Nanoscience Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group
Recent Patents on Cardiovascular Drug Discovery From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease
Current Psychopharmacology Advances in Studies on Stroke-Induced Secondary Neurodegeneration (SND) and Its Treatment
Current Topics in Medicinal Chemistry Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design Wound Healing Effects of Curcumin: A Short Review
Current Pharmaceutical Biotechnology Anticholinesterase and Pharmacokinetic Profile of Phenserine in Healthy Elderly Human Subjects
Current Alzheimer Research Psychotropic Medications and the Treatment of Human Prion Diseases
CNS & Neurological Disorders - Drug Targets